Overview

A Randomized, Open-Label, Single-Dose, Small Study to Evaluate the Safety and Effectiveness of Hydromorphone in Patients With Short Term, Moderate to Severe Postoperative Pain

Status:
Completed

Trial end date:
2001-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this small study was to investigate the safety and effectiveness of OROS hydromorphone HCI for the treatment of short-term, moderate to severe postoperative pain following total knee replacement surgery.

Phase:

Phase 2

Details

Lead Sponsor:

Alza Corporation, DE, USA

Treatments:

Hydromorphone